First trimester screening of serum advanced glycation end products levels of pregnant women who have risk factors for gestational diabetes and their obstetric outcomes: a preliminary case-control study

• Published in: Journal of obstetrics and gynaecology Vol. 42; no. 7; p. 3048
• Main Authors: Gurbuz, Ozge, Yorgancı, Ayçağ, Ozgu-Erdinc, A Seval, Tasci, Yasemin
• Format: Journal Article
• Language: English
• Published: England 03.10.2022
• Subjects: Case-Control Studies; Diabetes, Gestational; Female; Glycation End Products, Advanced; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Pregnant Women; Risk Factors; adverse prenatal outcome; Advanced glycation end-products; first-trimester; gestational diabetes

Advanced glycation end-products (AGE) are complex compounds formed by nonenzymatic glycosylation of proteins, nucleic acids, and lipids with glucose in the blood. We aimed to investigate whether there was a difference in first-trimester serum AGE levels of pregnant women with and without risk factor...